1.
J Manag Care Spec Pharm
; 26(6): 696-700, 2020 Jun.
Article
in English
| MEDLINE
| ID: mdl-32463780
ABSTRACT
DISCLOSURES: No funding was required for this project. The authors are or have been members of the Format Executive Committee.
Subject(s)
Documentation/standards , Evidence-Based Medicine/standards , Managed Care Programs/standards , Pharmacopoeias as Topic/standards , Societies, Pharmaceutical/standards , Decision Making, Organizational , Drug Costs/standards , Evidence-Based Medicine/economics , Evidence-Based Medicine/organization & administration , Managed Care Programs/economics , Managed Care Programs/organization & administration , Off-Label Use/economics , Off-Label Use/standards , United States
2.
J Manag Care Pharm
; 18(3): 268-75, 2012 Apr.
Article
in English
| MEDLINE
| ID: mdl-22468736
ABSTRACT
In the last 2 decades, health care management has been challenged by more aggressive therapy, the increased number of specialty medications, and more stringent guidelines to monitor adverse events or health risk. To promote patient safety, various communication requirements are mandated to increase the risk awareness of patients and physicians. These include black-box warnings, "Dear Health Care Provider" letters, U.S. Food and Drug Administration (FDA) Talk Papers, MedGuides, and Risk Minimization Action Plans (RiskMAPs).
